Cargando…
Infección nosocomial en el paciente receptor de un trasplante de órgano sólido o de precursores hematopoyéticos()
Bacterial infections are the most common infections in solid organ transplant recipients. These infections occur mainly in the first month after transplantation and are hospital-acquired. Nosocomial infections cause significant morbidity and are the most common cause of mortality in this early perio...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier España, S.L. y Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7103322/ https://www.ncbi.nlm.nih.gov/pubmed/24950613 http://dx.doi.org/10.1016/j.eimc.2014.05.002 |
_version_ | 1783512032901857280 |
---|---|
author | Moreno Camacho, Asunción Ruiz Camps, Isabel |
author_facet | Moreno Camacho, Asunción Ruiz Camps, Isabel |
author_sort | Moreno Camacho, Asunción |
collection | PubMed |
description | Bacterial infections are the most common infections in solid organ transplant recipients. These infections occur mainly in the first month after transplantation and are hospital-acquired. Nosocomial infections cause significant morbidity and are the most common cause of mortality in this early period of transplantation. These infections are caused by multi-drug resistant (MDR) microorganisms, mainly Gram-negative enterobacteria, non-fermentative Gram-negative bacilli, enterococci, and staphylococci. The patients at risk of developing nosocomial bacterial infections are those previously colonized with MDR bacteria while on the transplant waiting list. Intravascular catheters, the urinary tract, the lungs, and surgical wounds are the most frequent sources of infection. Preventive measures are the same as those applied in non-immunocompromised, hospitalized patients except in patients at high risk for developing fungal infection. These patients need antifungal therapy during their hospitalization, and for preventing some bacterial infections in the early transplant period, patients need vaccinations on the waiting list according to the current recommendations. Although morbidity and mortality related to infectious diseases have decreased during the last few years in haematopoietic stem cell transplant recipients, they are still one of the most important complications in this population. Furthermore, as occurs in the general population, the incidence of nosocomial infections has increased during the different phases of transplantation. It is difficult to establish general preventive measures in these patients, as there are many risk factors conditioning these infections. Firstly, they undergo multiple antibiotic treatments and interventions; secondly, there is a wide variability in the degree of neutropenia and immunosuppression among patients, and finally they combine hospital and home stay during the transplant process. However, some simple measures could be implemented to improve the current situation. |
format | Online Article Text |
id | pubmed-7103322 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Elsevier España, S.L. y Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71033222020-03-31 Infección nosocomial en el paciente receptor de un trasplante de órgano sólido o de precursores hematopoyéticos() Moreno Camacho, Asunción Ruiz Camps, Isabel Enferm Infecc Microbiol Clin Article Bacterial infections are the most common infections in solid organ transplant recipients. These infections occur mainly in the first month after transplantation and are hospital-acquired. Nosocomial infections cause significant morbidity and are the most common cause of mortality in this early period of transplantation. These infections are caused by multi-drug resistant (MDR) microorganisms, mainly Gram-negative enterobacteria, non-fermentative Gram-negative bacilli, enterococci, and staphylococci. The patients at risk of developing nosocomial bacterial infections are those previously colonized with MDR bacteria while on the transplant waiting list. Intravascular catheters, the urinary tract, the lungs, and surgical wounds are the most frequent sources of infection. Preventive measures are the same as those applied in non-immunocompromised, hospitalized patients except in patients at high risk for developing fungal infection. These patients need antifungal therapy during their hospitalization, and for preventing some bacterial infections in the early transplant period, patients need vaccinations on the waiting list according to the current recommendations. Although morbidity and mortality related to infectious diseases have decreased during the last few years in haematopoietic stem cell transplant recipients, they are still one of the most important complications in this population. Furthermore, as occurs in the general population, the incidence of nosocomial infections has increased during the different phases of transplantation. It is difficult to establish general preventive measures in these patients, as there are many risk factors conditioning these infections. Firstly, they undergo multiple antibiotic treatments and interventions; secondly, there is a wide variability in the degree of neutropenia and immunosuppression among patients, and finally they combine hospital and home stay during the transplant process. However, some simple measures could be implemented to improve the current situation. Elsevier España, S.L. y Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. 2014 2014-06-18 /pmc/articles/PMC7103322/ /pubmed/24950613 http://dx.doi.org/10.1016/j.eimc.2014.05.002 Text en Copyright © 2014 Elsevier España, S.L. y Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Moreno Camacho, Asunción Ruiz Camps, Isabel Infección nosocomial en el paciente receptor de un trasplante de órgano sólido o de precursores hematopoyéticos() |
title | Infección nosocomial en el paciente receptor de un trasplante de órgano sólido o de precursores hematopoyéticos() |
title_full | Infección nosocomial en el paciente receptor de un trasplante de órgano sólido o de precursores hematopoyéticos() |
title_fullStr | Infección nosocomial en el paciente receptor de un trasplante de órgano sólido o de precursores hematopoyéticos() |
title_full_unstemmed | Infección nosocomial en el paciente receptor de un trasplante de órgano sólido o de precursores hematopoyéticos() |
title_short | Infección nosocomial en el paciente receptor de un trasplante de órgano sólido o de precursores hematopoyéticos() |
title_sort | infección nosocomial en el paciente receptor de un trasplante de órgano sólido o de precursores hematopoyéticos() |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7103322/ https://www.ncbi.nlm.nih.gov/pubmed/24950613 http://dx.doi.org/10.1016/j.eimc.2014.05.002 |
work_keys_str_mv | AT morenocamachoasuncion infeccionnosocomialenelpacientereceptordeuntrasplantedeorganosolidoodeprecursoreshematopoyeticos AT ruizcampsisabel infeccionnosocomialenelpacientereceptordeuntrasplantedeorganosolidoodeprecursoreshematopoyeticos |